Through my research, I have provided new insight into the genetic and environmental causes of lung cancer. This has contributed to developing and testing novel lung cancer therapies. I have also identified the role of specific genes that normally control cell growth and survival but become drivers of abnormal cancerous growth in a mutated form. My recent investigations have focused on understanding the sensitivity and resistance to targeted therapies and immunotherapy, with the goal of developing new and better combination therapies for lung cancer patients.